Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Prognostic Utility of Serum TARC, MDC, IL10, and Soluble CD163 Levels with Positron Emission Tomography (PET) Response-Adapted Therapy for Advanced-Stage Hodgkin Lymphoma (HL): a SWOG S0816 US Intergroup Correlative Study

Eric D. Hsi, MD, Hongli Li, MS, Andrew B. Nixon, PhD, Andrew M Evens, DO,MSc, Heiko Schoder, MD, David J. Straus, MD, Nancy L. Bartlett, MD, John William Sweetenham, MDFRCP, Paul M. Barr, MD, Michelle A. Fanale, MD, James R. Cook, MD PhD, Brad S Kahl, MD, John P. Leonard, MD, Sonali M. Smith, MD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD, Oliver W. Press, MD PhD

Blood (2017) 130 (Supplement 1): 4033.

https://doi.org/10.1182/blood.V130.Suppl_1.4033.4033

Published: 2017

Journal Articles

Neutropenic Fever During Stem Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Poor Survival Following Autologous Stem Cell Transplantation,

Hien Duong, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, John William Sweetenham, MD, Brad Pohlman, MD, Robert Dean, MD, Steven Andresen, DO, Matt Kalaycio, MD, Ronald Sobecks, MD, Anna Koo, MD, Edward A. Copelan, MD

Blood (2011) 118 (21): 4053.

https://doi.org/10.1182/blood.V118.21.4053.4053

Published: 2011

Journal Articles

Intrathecal Chemotherapy Prophylaxis for CNS Relapse of DLBCL In the RCHOP Era: A Single Center Analysis.

Christopher Scott Kovacs, Jr., MD, John William Sweetenham, MD, FRCP, Marc Earl, Pharm., D., R.Ph., Robert Dean, MD, Brad Pohlman, MD, Brian Bolwell, MD, Stephen D. Smith, MD, BS

Blood (2010) 116 (21): 2804.

https://doi.org/10.1182/blood.V116.21.2804.2804

Published: 2010

Journal Articles

Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) + Rituximab In Relapsed DLBCL Patients Followed by Stem Cell Transplantation: Preliminary Safety and Efficacy

Nina Wagner-Johnston, Andre Goy, MD, Tatyana Feldman, MD, Yeow Tee Goh, MD, Cheolwon Suh, MD, John William Sweetenham, MD, FRCP, Christine Powell, Sharon T. Sullivan, PhD, Erik R. Vandendries, MD, PhD, Christian Gisselbrecht, MD

Blood (2010) 116 (21): 2883.

https://doi.org/10.1182/blood.V116.21.2883.2883

Published: 2010

Journal Articles

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Aleksandr Lazaryan, MD, MPH, PhD, Rachid Baz, MD, Mohamad A Hussein, Jr, MD, Paul Elson, ScD, Beth Faiman, CNP, Becky Habecker, Mary Ann Karam, RN, Janice Reed, RN, Kimberly Hamilton, RN, Kellie Bruening, Gordan Srkalovic, MD, PhD, Steven Andresen, DO, Matt Kalaycio, MD, John William Sweetenham, MD, FRCP, Ronald Sobecks, MD, Robert Dean, MD, Robert Knight, MD, Jerome B. Zeldis, MD, PhD, Frederic J. Reu, MD

Blood (2010) 116 (21): 1967.

https://doi.org/10.1182/blood.V116.21.1967.1967

Published: 2010

Journal Articles

Analysis of Readmission After Autologous HCT: Predictive Factors and Clinical Consequences

Sanjay R. Mohan, MD, Lisa Rybicki, MS, Stephen D. Smith, MD, Robert Dean, MD, Brad Pohlman, MD, John William Sweetenham, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steven Andresen, DO, Edward A. Copelan, MD, Brian J. Bolwell, MD

Blood (2010) 116 (21): 932.

https://doi.org/10.1182/blood.V116.21.932.932

Published: 2010

Journal Articles

Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant

Hien Duong, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Steven Andresen, DO, Ronald Sobecks, MD, Robert Dean, MD, John William Sweetenham, MD, FRCP, Shawnda Tench, Edward A. Copelan, MD

Blood (2010) 116 (21): 1340.

https://doi.org/10.1182/blood.V116.21.1340.1340

Published: 2010

Journal Articles

Validation of the Mantle Cell Lymphoma Prognostic Index (MIPI): A Valuable Tool for Risk Stratification in Mantle Cell Lymphoma.

Stephen Douglas Smith, MD, Eric D. Hsi, MD, Brian J. Bolwell, Amanda Maggiotto, B.S., Meagan Effinger, B.A., John William Sweetenham, MD

Blood (2009) 114 (22): 2703.

https://doi.org/10.1182/blood.V114.22.2703.2703

Published: 2009

Journal Articles

Non-Relapse Mortality Exceeds Relapse Mortality Six Years After Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.

Brian T. Hill, Lisa Rybicki, Brian J. Bolwell, Stephen Smith, Robert Dean, Matt E Kalaycio, MD, Brad Pohlman, Shawnda Tench, Ronald Sobecks, Steven Andresen, Edward Copelan, John William Sweetenham

Blood (2009) 114 (22): 3325.

https://doi.org/10.1182/blood.V114.22.3325.3325

Published: 2009

Journal Articles

Superior Survival in Non-Hodgkin Lymphoma Following Autologous Stem Cell Transplantation with Intravenous Busulfan, Cyclophosphamide, and Etoposide.

Robert Dean, Lisa Rybicki, Brad Pohlman, John William Sweetenham, Stephen Smith, Edward Copelan, Ronald Sobecks, Matt Kalaycio, Steven Andresen, Shawnda Sungren, Brian J. Bolwell, MD

Blood (2008) 112 (11): 2186.

https://doi.org/10.1182/blood.V112.11.2186.2186

Published: 2008

Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Blood (2008) 112 (11): 475.

https://doi.org/10.1182/blood.V112.11.475.475

Published: 2008

Journal Articles

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Christy Stotler, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Edward A. Copelan, Steven Andresen, Brad Pohlman, John William Sweetenham, Lisa Rybicki, Stacey Brown, Kim Bell, Kelly Cherni, Laura Bernhard, Christina Ferraro, Brian J. Bolwell

Blood (2007) 110 (11): 1671.

https://doi.org/10.1182/blood.V110.11.1671.1671

Published: 2007

Journal Articles

Numbers of Lymphoma Associated Macrophages (LAMS) and Regulatory T-Cells (Tregs) in Follicular Lymphoma (FL) Patients (pts) Treated with and without Monoclonal Antibody (MoAb)-Containing Therapy Do Not Correlate with Overall Survival (OS): A Study from the Southwest Oncology Group (SWOG).

John William Sweetenham, Eric Hsi, Bryan Goldman, Michael LeBlanc, Raymond R. Tubbs, James R. Cook, Oliver W. Press, Richard I. Fisher, Lisa M. Rimsza

Blood (2007) 110 (11): 2602.

https://doi.org/10.1182/blood.V110.11.2602.2602

Published: 2007

Journal Articles

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Edward Copelan, MD, Ronald Sobecks, MD, Robert Dean, MD, Lisa Rybicki, Stacey Brown, Matt Kalaycio, MD, Brad Pohlman, MD, John William Sweetenham, MD, Steven Andresen, DO, Brian Bolwell, MD

Blood (2007) 110 (11): 5003.

https://doi.org/10.1182/blood.V110.11.5003.5003

Published: 2007

Journal Articles

Are Back-Up Bone Marrow Harvests of Value in Unrelated Donor Allogeneic Transplants?.

Christy Stotler, Edward Copelan, Ronald Sobecks, Lisa Rybicki, Robert Dean, Steven Andresen, Brad Pohlman, John William Sweetenham, Stacey Brown, Matt Kalaycio, Julie Curtis, Karen Sands, Mary Serafin, Jennifer Kosar, Brian Bolwell

Blood (2007) 110 (11): 5023.

https://doi.org/10.1182/blood.V110.11.5023.5023

Published: 2007

Journal Articles

Disappointing Outcomes of Peripheral T Cell Lymphoma after Autologous Stem Cell Transplantation.

Stephen D. Smith, MD, John William Sweetenham, MD, Lisa Rybicki, MS, Stacey Brown, BA, Robert M. Dean, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steve Andresen, DO, Eric His, MD, Brad Pohlman, MD, Brian J. Bolwell, MD

Blood (2006) 108 (11): 5428.

https://doi.org/10.1182/blood.V108.11.5428.5428

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma: Adverse Events Occurring 5 Years and Beyond.

Brian Bolwell, John William Sweetenham, Lisa Rybicki, Ronald Sobecks, Robert Dean, Steven Andresen, Stacey Brown, Matt Kalaycio, Brad Pohlman

Blood (2006) 108 (11): 5335.

https://doi.org/10.1182/blood.V108.11.5335.5335

Published: 2006

Journal Articles

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, MD, Karl Theil, MD, Lisa Rybicki, MS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Mary Serafin, RN, Karen Sands, RN, Jennifer Kosar, RN, Brian J. Bolwell, MD

Blood (2006) 108 (11): 2960.

https://doi.org/10.1182/blood.V108.11.2960.2960

Published: 2006

Journal Articles

The Use of Intravenous Compared with Oral Busulfan in High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) for Lymphoma Is Associated with Improved Relapse-Free Survival.

Robert Dean, Brad Pohlman, John William Sweetenham, Ronald Sobecks, Matt Kalaycio, Steven Andresen, Lisa Rybicki, Christopher Lowe, Stacey Brown, Julie Curtis, Brian Bolwell

Blood (2006) 108 (11): 3050.

https://doi.org/10.1182/blood.V108.11.3050.3050

Published: 2006

Journal Articles

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Ronald Sobecks, MD, Edward J. Ball, PhD, Medhat Askar, MD, PhD., Karl Theil, MD, Lisa Rybicki, MS, Dawn Thomas, CHS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Jaroslaw P. Maciejewski, MD, MS, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3012.

https://doi.org/10.1182/blood.V108.11.3012.3012

Published: 2006

NARROW

Prognostic Utility of Serum TARC, MDC, IL10, and Soluble CD163 Levels with Positron Emission Tomography (PET) Response-Adapted Therapy for Advanced-Stage Hodgkin Lymphoma (HL): a SWOG S0816 US Intergroup Correlative Study

Neutropenic Fever During Stem Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Poor Survival Following Autologous Stem Cell Transplantation,

Intrathecal Chemotherapy Prophylaxis for CNS Relapse of DLBCL In the RCHOP Era: A Single Center Analysis.

Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) + Rituximab In Relapsed DLBCL Patients Followed by Stem Cell Transplantation: Preliminary Safety and Efficacy

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Analysis of Readmission After Autologous HCT: Predictive Factors and Clinical Consequences

Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant

Validation of the Mantle Cell Lymphoma Prognostic Index (MIPI): A Valuable Tool for Risk Stratification in Mantle Cell Lymphoma.

Non-Relapse Mortality Exceeds Relapse Mortality Six Years After Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.

Superior Survival in Non-Hodgkin Lymphoma Following Autologous Stem Cell Transplantation with Intravenous Busulfan, Cyclophosphamide, and Etoposide.

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Numbers of Lymphoma Associated Macrophages (LAMS) and Regulatory T-Cells (Tregs) in Follicular Lymphoma (FL) Patients (pts) Treated with and without Monoclonal Antibody (MoAb)-Containing Therapy Do Not Correlate with Overall Survival (OS): A Study from the Southwest Oncology Group (SWOG).

Birth Order Does Not Affect Outcome in HLA-Identical Sibling Transplantation.

Are Back-Up Bone Marrow Harvests of Value in Unrelated Donor Allogeneic Transplants?.

Disappointing Outcomes of Peripheral T Cell Lymphoma after Autologous Stem Cell Transplantation.

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma: Adverse Events Occurring 5 Years and Beyond.

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

The Use of Intravenous Compared with Oral Busulfan in High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) for Lymphoma Is Associated with Improved Relapse-Free Survival.

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only